Keywords: lilly, gemzar, moves, closer, market, eli, new

Lilly's Gemzar Moves Closer To US Market

Article | 31 July 1995

Print This

Eli Lilly's new anticancer drug Gemzar (gemcitabine) has been recommended for approval by the US Food and Drug Administration's Oncologic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in